Intrinsic Alertness Is Impaired in Patients with Nigrostriatal Degeneration: A Prospective Study with Reference to [123I]FP-CIT SPECT and [18F]FDG PET.
Aged
Aged, 80 and over
Attention
/ physiology
Brain
/ diagnostic imaging
Female
Fluorodeoxyglucose F18
Humans
Lewy Body Disease
/ diagnostic imaging
Male
Middle Aged
Neostriatum
/ diagnostic imaging
Positron-Emission Tomography
Prospective Studies
Radiopharmaceuticals
Single Photon Emission Computed Tomography Computed Tomography
Substantia Nigra
/ diagnostic imaging
Tropanes
Wakefulness
/ physiology
Alertness
Lewy body diseases
[123I]FP-CIT SPECT
[18F]FDG PET
dementia with Lewy bodies
fluctuations
Journal
Journal of Alzheimer's disease : JAD
ISSN: 1875-8908
Titre abrégé: J Alzheimers Dis
Pays: Netherlands
ID NLM: 9814863
Informations de publication
Date de publication:
2020
2020
Historique:
pubmed:
21
11
2020
medline:
30
9
2021
entrez:
20
11
2020
Statut:
ppublish
Résumé
Variations in alertness and attention are common in Lewy body diseases (LBD) and among the core features of dementia with Lewy bodies (DLB). Dopamine transporter SPECT is an accurate biomarker of nigrostriatal degeneration (NSD) in LBD. The present study investigated performance on a computerized alertness test as a potential measure of attention in patients with NSD compared to patients without NSD. Thirty-six patients with cognitive impairment plus at least one core feature of DLB referred for [123I]FP-CIT SPECT imaging were prospectively recruited. Performance in a computerized test of intrinsic alertness was compared between patients with and those without NSD as assessed by [123I]FP-CIT SPECT. Reaction times to auditory stimuli (adjusted for age, sex, and education) were significantly longer in patients with NSD compared to those with a normal [123I]FP-CIT SPECT scan (p < 0.05). Statistical analyses revealed no significant differences comparing reaction times to visual stimuli or dispersion of reaction times between groups. Exploratory analysis in a subgroup of patients with available [18F]FDG PET revealed that longer reaction times were associated with decreased glucose metabolism in the prefrontal cortex (statistical parametric mapping, adjusted for age and sex; p < 0.005, cluster extent > 50 voxels). Computerized assessment of auditory reaction times is able to detect alertness deficits in patients with NSD and might help to measure alertness deficits in patients with LBD and NSD. Future studies in larger samples are needed to evaluate the diagnostic utility of computerized alertness assessment for the differential diagnosis of LBD.
Sections du résumé
BACKGROUND
Variations in alertness and attention are common in Lewy body diseases (LBD) and among the core features of dementia with Lewy bodies (DLB). Dopamine transporter SPECT is an accurate biomarker of nigrostriatal degeneration (NSD) in LBD.
OBJECTIVE
The present study investigated performance on a computerized alertness test as a potential measure of attention in patients with NSD compared to patients without NSD.
METHODS
Thirty-six patients with cognitive impairment plus at least one core feature of DLB referred for [123I]FP-CIT SPECT imaging were prospectively recruited. Performance in a computerized test of intrinsic alertness was compared between patients with and those without NSD as assessed by [123I]FP-CIT SPECT.
RESULTS
Reaction times to auditory stimuli (adjusted for age, sex, and education) were significantly longer in patients with NSD compared to those with a normal [123I]FP-CIT SPECT scan (p < 0.05). Statistical analyses revealed no significant differences comparing reaction times to visual stimuli or dispersion of reaction times between groups. Exploratory analysis in a subgroup of patients with available [18F]FDG PET revealed that longer reaction times were associated with decreased glucose metabolism in the prefrontal cortex (statistical parametric mapping, adjusted for age and sex; p < 0.005, cluster extent > 50 voxels).
CONCLUSION
Computerized assessment of auditory reaction times is able to detect alertness deficits in patients with NSD and might help to measure alertness deficits in patients with LBD and NSD. Future studies in larger samples are needed to evaluate the diagnostic utility of computerized alertness assessment for the differential diagnosis of LBD.
Identifiants
pubmed: 33216022
pii: JAD191277
doi: 10.3233/JAD-191277
doi:
Substances chimiques
Radiopharmaceuticals
0
Tropanes
0
Fluorodeoxyglucose F18
0Z5B2CJX4D
2-carbomethoxy-8-(3-fluoropropyl)-3-(4-iodophenyl)tropane
155797-99-2
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM